N
Google TrendPANTHERS VS BLUE JACKETS (200+) — Gameday 7: Florida Panthers at Columbus Blue Jackets
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:panthers vs blue jackets200+posiciones de atlético de madrid contra manchester united5000+devils vs red wings2000+lioness season 35000+tresoldi200+street fighter movie early reviews2000+luis díaz200+halle berry child custody hearing200+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Long-Term Survival Gains" (30 stories)

Top Headline Story

Long-Term Survival Gains Cement Pembrolizumab’s Role in Early Triple-Negative Breast Cancer
Lead StoryDocWireNewstech
Jun 30

Long-Term Survival Gains Cement Pembrolizumab’s Role in Early Triple-Negative Breast Cancer

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxNOE1hT0Z3d1lxbUx5WVd5R093Ry03NjFoazRmekkweW1TVkhjcmd0OUJJUHBTdVdvVkF5Z01NVUlWVXNTWGs2aVpOWl9TNDJtX1loMFFVeERoX1E5a2ZLdEdfME04Y1ItVm5Hc0tQenEtNWV1a1hlYXdNdFFqdnR4Z2p2Sk0zdlAybzVpblZTaUxBTlpIMWd0R2o1VFZMX0tHeVl3U0RsMmt2RXNnQWM5cTNaQmt5S1ZOUXhEeXl5THpqT2M?oc=5" target="_blank">Long-Term Survival Gains Cement Pembrolizumab’s Role in Early Triple-Negative Breast Cancer</a>  <font color="#6f6f6f">DocWireNews</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+16m ago

panthers vs blue jackets

Gameday 7: Florida Panthers at Columbus Blue Jackets

Filter stories
5000+26m ago

posiciones de atlético de madrid contra manchester united

Atlético 2 - 0 Manchester United: resumen, goles y resultado de la Champions League

Filter stories
2000+26m ago

devils vs red wings

Devils at Red Wings projected lineups

Filter stories
5000+26m ago

lioness season 3

Thank Zoe Saldaña for ‘Lioness’ Season 3’s Perfect Cliff-Hanger

Filter stories

Search Results for "Long-Term Survival Gains"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Survival Gains Confirmed: Full KEYNOTE-522 Data Set to Redefine Treatment Standards in Early-Stage TNBC at ASCO 2026
OncLivetech

Survival Gains Confirmed: Full KEYNOTE-522 Data Set to Redefine Treatment Standards in Early-Stage TNBC at ASCO 2026

<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxNbHdGSHhPYVI0dEc5dEluNGh1b3d0VDA5aGJfZURPME1uaGgzTlhiR1kyRmt6cWI1VWE0NGV4OG5xVUlvS3hsU0x3NmNkYXcxNGVnU05xRWVuXzRXQmUxN2lfTHB1UVNmOWs2WmUydlNoSDJTbUcySXVhM2lIY0FUZVg0ZnZ5OFJYWWdhNVBhTlp2Z3plb05vZDNNMmd0d0M2blZXR0FqLW13Z0hJNTlfQ084N21GNDdDTEFKbmJLMzg5YlpudFotQXFCVlJwZThsUUdpeHUtNS1ScjRI?oc=5" target="_blank">Survival Gains Confirmed: Full KEYNOTE-522 Data Set to Redefine Treatment Standards in Early-Stage TNBC at ASCO 2026</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
Pediatric Cancer in the 2000s: Uneven Survival Gains Seen
Medscapetech

Pediatric Cancer in the 2000s: Uneven Survival Gains Seen

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxOdGFpdVBLLVRJcjcwVEk2bmlGSi1jQ0VEUWJwQXZJc2pWN0QtR0U1dmtiMTY4NFQxeDZlcUFadURWd2habVN3U1prVzlHeVU1QkpaMVRnWFM1YTZocWtEdjNWdF92dm9pVU1KQ1FOTDhVUHVlT0djSnhReTVKWUNFZzJUckExbm1SSndpZmFtWjlXUmpvNzY1dFRKeTdBMnpz?oc=5" target="_blank">Pediatric Cancer in the 2000s: Uneven Survival Gains Seen</a>  <font color="#6f6f6f">Medscape</font>

Read Full StoryMore like this
Understanding Cancer Survivorship, Quality of Life and Caregivers
Cure Todayworld

Understanding Cancer Survivorship, Quality of Life and Caregivers

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQM1lTVDF0NUM4ZzhMMkVaNUVodENzci1pZkM4QUlmVGlsWjRJbVVlcVVnT2pMVlRiX2lwTWg1ZmZSS1ZPNkFKc3NpUjRrSHFRaHFDRFRvbGNxczVuQ3AyNFU0LXVDQi0wQ2VMSmpScjJnUUIxbkhaNExhUkVkQk8tOC1oQUhWSzRFclk5WWtKVGFfMi1NNWVNOTVPWQ?oc=5" target="_blank">Understanding Cancer Survivorship, Quality of Life and Caregivers</a>  <font color="#6f6f6f">Cure Today</font>

Read Full StoryMore like this
Survival Gains in AML Shadowed by Lasting Morbidity
The American Journal of Managed Caretech

Survival Gains in AML Shadowed by Lasting Morbidity

<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxObGdFU2U1X3YwV2xyQW00VUtnTWtza3MtRUhwaUpISWkycmt5Qm1Yck0wVXpXQWhidmJaQXV1VE1uUG0ydFFkbnhrVGhocktJUVZ1UXQtUkFPc2NJdDhhT1FhZWwtamdwUTZqV3kyNVlfbTBDcDdIbDc2Mk0zVHdTUVZMVQ?oc=5" target="_blank">Survival Gains in AML Shadowed by Lasting Morbidity</a>  <font color="#6f6f6f">The American Journal of Managed Care</font>

Read Full StoryMore like this
Brain tumor vaccine links mutation targeting to eight-year survival gains
Medical Xpresstech

Brain tumor vaccine links mutation targeting to eight-year survival gains

<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxPdmNpQUhrREZYbUVjTy1kcWtKRE5NSGNwRkpKSEZwU1hnX2oxdkl2OTZvbEdGSU5fZTRBNFlQM052ZkpWbmVzM3E3Rk9NRXZUeVN5X1hhZzRDT3hxdEpmclU4OWtWZTV0dWFNNlRtRUs4bXRMX0J0d3I3ZllldEhzSzNMUWg?oc=5" target="_blank">Brain tumor vaccine links mutation targeting to eight-year survival gains</a>  <font color="#6f6f6f">Medical Xpress</font>

Read Full StoryMore like this
Lung Cancer Survival Rates Show Meaningful Gains
Clinical Oncology Newstech

Lung Cancer Survival Rates Show Meaningful Gains

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxQTE1aWHYyQWJLVTN3TkZVbWRTZVlaV0JDUTdqanoyRi1hUFdQOTBzM0h4aGxaWXo1UzFRNnEyQl9Da3U2YnlReVIzajBnWXlyYzdSYlF2LVZTSmx2d0NiSDRVMDFwWlZ6YU1sYmRXaldJNmZmWnBoeXhpVUgyTHFqU1RfalRiZElONGVpbExhV212V2VtTVBMeDJWX3pWQkF2SU1tZE5yZ0VFZ3VmNHlvdmc2bw?oc=5" target="_blank">Lung Cancer Survival Rates Show Meaningful Gains</a>  <font color="#6f6f6f">Clinical Oncology News</font>

Read Full StoryMore like this
Enzalutamide/Radium-223 Offers Long-Term Gains in mCRPC
Oncology Nursing Newstech

Enzalutamide/Radium-223 Offers Long-Term Gains in mCRPC

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxOZTBJbzZFRFFzWE45bFM2Qi02NVlvbFFtRVB4UnE0aVo5QkJZN1ZKbGtLaUltMTYyZko0eG5ycnBPelZuNkJZbkZwVFh4SHk5MEhDeFE1LXZEWEFsbHdjQWpHdmJqUDlBdVJMSmVkU1VwSzBZd1lhZV8weV90SWpGTWRsZUxSRUFzTEJJZ1c4a1pWeWRaMHc?oc=5" target="_blank">Enzalutamide/Radium-223 Offers Long-Term Gains in mCRPC</a>  <font color="#6f6f6f">Oncology Nursing News</font>

Read Full StoryMore like this
A New Therapeutic Era in Metastatic Castration-Resistant Prostate Cancer
Pharmacy Timesgeneral

A New Therapeutic Era in Metastatic Castration-Resistant Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxObGd2TGpYS051YVlRa3BWOW16aGQxYmR3bXFEYlVIU2VybE5LRHVrQVlueEVhczFXUjVkMGlSOEpTSlVBOEFmV3VBczVVdkhSc3laaC1TVnVnUERWejA1cmlmZVRacEMxVkNCbUtqSnhYUE14eVA1NVF1ZG5laDNoVHpRM2JJUDdjT2VLTFpkT1NBakh6RENnSWhaN3piRUFYMEtDQkV5VUIyUGc?oc=5" target="_blank">A New Therapeutic Era in Metastatic Castration-Resistant Prostate Cancer</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
Tislelizumab Plus Chemotherapy in ES-SCLC Delivers Sustained Survival Benefit in Long-Term Follow-Up of RATIONALE-312
Oncodailytech

Tislelizumab Plus Chemotherapy in ES-SCLC Delivers Sustained Survival Benefit in Long-Term Follow-Up of RATIONALE-312

<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxOZzctUXZ5U29WUzlQOEJDTTRzazd6b2RGZzlSdUFlUGl0TnlvcTZZLVFFVkg4by1BdHJMbkVYeXp2d3lwVFB1cmd2Tk1SV0EzWVhQZEM3SGU2Ukl6ck1rVDUxVTdfdHcwNDczMVRDSUd5MGNFVVd4alV3eEx2cU80Yg?oc=5" target="_blank">Tislelizumab Plus Chemotherapy in ES-SCLC Delivers Sustained Survival Benefit in Long-Term Follow-Up of RATIONALE-312</a>  <font color="#6f6f6f">Oncodaily</font>

Read Full StoryMore like this
Mind the Gap: The growing divide between lifespan and good health
American Council on Science and Healthscience

Mind the Gap: The growing divide between lifespan and good health

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNclJKb0RJZVBRRnlYbVM5eWRwWVo1SjdZM1NNbXZMSVdBNzM2RDBnTTQ5bXAzQ0UwekJVeUJxMTFob3JpU3ZDQnJYckptYkI4VU1oRFNNYUlDcy1pZVR1WmE1MlVGeEZPRWlwOFJWOEFsZXRORTczZzZjOEdHb1dnUGNIMDhobTRPdjBXaFhRRmUyNzlyVm1Wdk0wNXp5cmJv?oc=5" target="_blank">Mind the Gap: The growing divide between lifespan and good health</a>  <font color="#6f6f6f">American Council on Science and Health</font>

Read Full StoryMore like this
Medicaid expansion linked to better survival in resectable lung cancer, study finds
Managed Healthcare Executivetech

Medicaid expansion linked to better survival in resectable lung cancer, study finds

<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxPYlY3VllLUEpPeVIxRmFTMDQtdFhnanlnSFdOdDFuc2ZEckt6MUJmU3BhaktNVGtZMEdPUWNQQmhESjhqcFl0TG5kNW0wRVBLRjBFZDRIbktIbTNoMGpqVzhJZ1NLUEt2eDNlbEppTDZjTFhpd0JGOXlZXzItQ3lsN1p4dVhBS2NLeGZrR1J2VXBBZTl2a1p0bTRRcWhPV0hjQXE4VmZ6X3oxeUtZbV9vNTBjdkNmcXA0UXVkaHBoZHpSYlViZ2VLVzh3?oc=5" target="_blank">Medicaid expansion linked to better survival in resectable lung cancer, study finds</a>  <font color="#6f6f6f">Managed Healthcare Executive</font>

Read Full StoryMore like this
Interview: S. Africa's rhino conservation gains highlight need for sustained protection, says expert
Xinhuatech

Interview: S. Africa's rhino conservation gains highlight need for sustained protection, says expert

<a href="https://news.google.com/rss/articles/CBMifEFVX3lxTFBhUWZ1Z0s3V2VEemJubmxyeDVyMVpfN1FidXdXcTZudjJSYUVPY2tSZkFKYWd5RUhDZ3QweXJWYkhETWxxcFk5aklVaTFjQlN6RTRLSHhxM1Y2WE82c1k2UXhoRDA5Q2FhYVhZVmMyVWVGY25IWWdndzRsb0I?oc=5" target="_blank">Interview: S. Africa's rhino conservation gains highlight need for sustained protection, says expert</a>  <font color="#6f6f6f">Xinhua</font>

Read Full StoryMore like this
HER2+ Metastatic Gastroesophageal Adenocarcinoma: Why First-Line Innovation Can’t Wait
Fierce Pharmatech

HER2+ Metastatic Gastroesophageal Adenocarcinoma: Why First-Line Innovation Can’t Wait

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxPV196UjVEd2VvMFdiMXl4SkQtVHV1WDdFZ1VJX1lKdWh1NHFIU1ZvR2k0N3ZpSlVmQi1IZTF4Ukt1SV8zNG9ITVUxVjR4WWFrVDBZc2tFa2IydW1DaTFYRk9sM3VzS0J0WGlMTE1FMkE2SC13OTExTjhraFhiQXFGeGVoM1NyQ3d1ajhHWUw3d2tRbGY4OFF1ZmlLV0Nnb2tCLTd2Q1VVUE91aG9DQXdvbGZpMmFIZlVSZ3BCVFVxRQ?oc=5" target="_blank">HER2+ Metastatic Gastroesophageal Adenocarcinoma: Why First-Line Innovation Can’t Wait</a>  <font color="#6f6f6f">Fierce Pharma</font>

Read Full StoryMore like this
New trial shows major survival gains with epcoritamab added to standard R2 therapy
News-Medicaltech

New trial shows major survival gains with epcoritamab added to standard R2 therapy

<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxQR0ZpUnFScjZCZ2I2dDFCeFFzRXdnWlZEY19RSHN6QUpNT1dNd1NzczRodE9mS3VfYmUxbHdISVJxMmJpT09zLXJIWGp1Z19Cc3BqZHZLWE5GRXFBQTMydGJNbkNGVkloMEZBUmYzSmQtNFYyVTZBczRaYnE5WElpWkFING9PNVNFeXJGeTdRSEwxZVdoNG02UXRVVDNjYThHRjFKRW5RbFFkUUJuaDFMdXhCRDJRWEhjclIzNGZDZGJwenhzbFkybzJB?oc=5" target="_blank">New trial shows major survival gains with epcoritamab added to standard R2 therapy</a>  <font color="#6f6f6f">News-Medical</font>

Read Full StoryMore like this
Stem cell transplants up, survival up: HHS study finds big gains for leukemia patients
Hamilton Health Sciencestech

Stem cell transplants up, survival up: HHS study finds big gains for leukemia patients

<a href="https://news.google.com/rss/articles/CBMifEFVX3lxTE1Gb1haR0JMQ29hMEtTNV9LWkM0RFRHZjdwbkV5aU1PRTZzV01TdVNmUGRoYTJVb1JUcVNoelBReGh3VUNwOTVpbEtDbjNyVjJBMDRManlqaDMzOGlfMF91TjdOQVUzaUJZZks4NVpuWFAxcWpXRGpGMGxMblQ?oc=5" target="_blank">Stem cell transplants up, survival up: HHS study finds big gains for leukemia patients</a>  <font color="#6f6f6f">Hamilton Health Sciences</font>

Read Full StoryMore like this
Loqtorzi Nearly Doubles Long-Term Survival in Nasopharyngeal Cancer
Cure Todaygeneral

Loqtorzi Nearly Doubles Long-Term Survival in Nasopharyngeal Cancer

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQUThpOVVHRFZVT3BPbElqQkNBekRkS2JvTHJSQkhjVFhFb3AxWnV3WHMxRERVUFYyRGlNZEFzVHMxS0RnTmZ5Q3dpU0dKZTVQdURzY3FtajV5cVRvRnlsX3htd0N2MmJNbDE5WDI0bmNaSVZMbWJERnpDQmQ0TV9LM0oyWWVJc3lBZXlzM1hSN2RHaGdSXzFvM1VaV1R0N1U?oc=5" target="_blank">Loqtorzi Nearly Doubles Long-Term Survival in Nasopharyngeal Cancer</a>  <font color="#6f6f6f">Cure Today</font>

Read Full StoryMore like this
ASCENT-04/KEYNOTE-D19: What a 3.4-Month PFS Gain Means for First-Line PD-(L)1–Positive mTNBC
DocWireNewstech

ASCENT-04/KEYNOTE-D19: What a 3.4-Month PFS Gain Means for First-Line PD-(L)1–Positive mTNBC

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxQNjJXV0lBbzFoREdPSktRcE9mMkgxZGNhWVRkcVRqR3ItaHpoQlZxTkNSLXR6c2RwOW95V2ZuLXdveHdmM3U4ZnVYLUZDQmM0ZUR5N3FDM2s4dnhBOWdNYlVRUjM4T2hkakJGZGNDa3VfcG9QUGdFdTl4NEExZkVZVVB5XzRfdkJmM1NLUGhaaDBvcWVLemI5WFo5RVctSkZTTlpMeFMwa2ZWcUJNTHJ1TkRvNGpmWS0wZnpCRlQ1RHFmZw?oc=5" target="_blank">ASCENT-04/KEYNOTE-D19: What a 3.4-Month PFS Gain Means for First-Line PD-(L)1–Positive mTNBC</a>  <font color="#6f6f6f">DocWireNews</font>

Read Full StoryMore like this
ALS Drug Tofersen Linked to Longer Survival, Strength Gains
Medscapetech

ALS Drug Tofersen Linked to Longer Survival, Strength Gains

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxPU3JFa3lNOFJRVUpmN0otbVAzSXpIRF9lOTY3enBxeFhaQU1rcU9VcU0xT0ppeWhkaFNXeTVZZzRQdFg3UjlKVEdxTkIwd2l6SE5DYk9RMERZc1FaVGJIcGhZZVJULUNmR0gyaTQ3YjNuQk1MZzZWVVZmZDN0QWgtQVE3OUY1UDVTMW1CRzgyYUdETVU0U1R4TlZFMHdzam9OdkpqRmxQT2o?oc=5" target="_blank">ALS Drug Tofersen Linked to Longer Survival, Strength Gains</a>  <font color="#6f6f6f">Medscape</font>

Read Full StoryMore like this
CLEOPATRA Trial: The Study That Changed HER2-Positive Metastatic Breast Cancer Forever
Oncodailygeneral

CLEOPATRA Trial: The Study That Changed HER2-Positive Metastatic Breast Cancer Forever

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE9DcG56Q3J2TDAtN3ZUNzFxLWRSZjZQbG9yNUdxai1YU1JId1pvWnBUSTFOZEh2Y2xfWE1aemhVNG9PN2pQY2h4dVBrb2htaktJaG0tSjRaZl8wSzNhN0hjMQ?oc=5" target="_blank">CLEOPATRA Trial: The Study That Changed HER2-Positive Metastatic Breast Cancer Forever</a>  <font color="#6f6f6f">Oncodaily</font>

Read Full StoryMore like this
Onconic Therapeutics reports complete response, survival gains with Nesuparib in pancreatic cancer - CHOSUNBIZ
Chosunbiztech

Onconic Therapeutics reports complete response, survival gains with Nesuparib in pancreatic cancer - CHOSUNBIZ

<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxPTlBrdkZNNEpmcVRRSDRQc2hhaENjYThfcGFnZkJFN1NldkdkV3hkMnp4UnFlWU42THphc1cweHBSSFF1MGtwUVBvUnhaU1V5VXpTel9NRFFhcmZDWTdOTG5DNjNiR0xpRGlYcUUzYmZvM1FXdzlELUlzcFNTMEl4UdIBlAFBVV95cUxNYTBNR2Y4eFdlV1hndU03d2xCVWV1b3d4a3NsWVR2R1F1Y0FqRV9KSzk3cXdwVHNzZVV6SjhfamxIR0UzcnZMY3YzNXRpbEhtVGdTSWZpNFMzLWtnWVRwQ1VUNE5JQzBEaVd2eUx5UXh1OFU2RjNTTEs3b09qNzFyNm05ang5V3N6QTZWZVh3ZGJpMXBq?oc=5" target="_blank">Onconic Therapeutics reports complete response, survival gains with Nesuparib in pancreatic cancer - CHOSUNBIZ</a>  <font color="#6f6f6f">Chosunbiz</font>

Read Full StoryMore like this
‘Stunning victory’: 70% of people with cancer survive at least 5 years
Healioworld

‘Stunning victory’: 70% of people with cancer survive at least 5 years

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxOWW80M3hLclpCam9wWHpIZ2d5VzFZWTd4bDJvMEJQengxYVRSQ2NtUkgyYW54VXNVbE1GYmN2Sy1aeHVnLURSZHdKSHlnemhPdHozdzY5RHM5SWlqUjVyR0ZSRDdoaFRPVks5RXltbkw1Q1FWdkVhblJka1VfYW5NUG1QWHEzM1VacGQ2bUhkMTltRzQ1NTFsVnhzcEZUUDhOOHVVQmRyZHhadERna0p3azhwNW9fbHdyQUdmSi1oVEk?oc=5" target="_blank">‘Stunning victory’: 70% of people with cancer survive at least 5 years</a>  <font color="#6f6f6f">Healio</font>

Read Full StoryMore like this
Orca-T Delivers Major Gains Beyond Conventional Prophylaxis in Hematologic Malignancies
OncLivetech

Orca-T Delivers Major Gains Beyond Conventional Prophylaxis in Hematologic Malignancies

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxOcnp0aERTYmVsbmp4bVY3NjdHWVFTXzZaZmlSMHBWYnY3YU83SVpfYmw3N1loTWhJTnMwN0g3azRQeGxiS09IQXpxOUxLWVRuSHJuU09DSGpxT1RCWmNnWlhXSF9DQjRtcTFvR2Qwd3Q1Ukh6enVfaTI4UHh5MkxIRjlLak9Id19xQW1MdVA5MjE4Mkludmt4LUdUWEFwaWtObi1jbC03ZzB0X3hpWXZMZG1DMEhJcjQ?oc=5" target="_blank">Orca-T Delivers Major Gains Beyond Conventional Prophylaxis in Hematologic Malignancies</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
Elraglusib Combo Yields Notable 24-Month Survival Benefit in Metastatic PDAC
Targeted Oncologygeneral

Elraglusib Combo Yields Notable 24-Month Survival Benefit in Metastatic PDAC

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxQWnAtMXJZUi0wRnpQendIbTdpMXp6Y2ZEQkhzSHZKWFlUcklIdVdYVGdRZmRaYWtEZWtWcFp2ZC1iTWs1OW9QVDZid0kzR1hYQ2ZocXFlYlFtbnNlWUFGQXZUbFdiSDhyOEpQdDlIQ0lMOU1YYlo1cUdJc04wN0d5ZVY0S2NIQm1sem11TzJlS2JOQjF2QjNXbWtlNTBIOEw4NnM3b0hPclB4SXhhNnc?oc=5" target="_blank">Elraglusib Combo Yields Notable 24-Month Survival Benefit in Metastatic PDAC</a>  <font color="#6f6f6f">Targeted Oncology</font>

Read Full StoryMore like this
Rethinking Rectal Cancer End Points: pCR Not a Survival Surrogate
Targeted Oncologygeneral

Rethinking Rectal Cancer End Points: pCR Not a Survival Surrogate

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQQjFaUzRnVXljTU9oeDVfZThZUHJibkZsck55Zld4Y2JZUnMyMEJJZzJZNS0tenhQbVFIZGl2THhEbzBMMjBISnE2NGFvM3dEbGIxU3lYZzBzVXpjR21iOXVIZDJRckliTHNLdl92VVBBR0U1SVIwMnczeFZ6a2RXbkx2OG40Q2ZJaVZXN0tsMldEaGhzZDM2NXRQNG1BUQ?oc=5" target="_blank">Rethinking Rectal Cancer End Points: pCR Not a Survival Surrogate</a>  <font color="#6f6f6f">Targeted Oncology</font>

Read Full StoryMore like this
Projected lives saved and economic value of mRNA cancer immunotherapies in the United States
The Lancetworld

Projected lives saved and economic value of mRNA cancer immunotherapies in the United States

<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxNR29NQmJFNm1ENXAwS0hRUUhIZUNIZXY2b3FnME9aa3NFLW1oVFRHS1ViSmRER1o1alc4aGFISkNfLThmX2hndExYMkYwSkxzOUM1cGs3VFg1UmdrRHlnZERYVzRqbXN6UU5VaVRqWmQyMDlWSUgzaXhEcDZkSWNCSExGZjN6SWNJYWc?oc=5" target="_blank">Projected lives saved and economic value of mRNA cancer immunotherapies in the United States</a>  <font color="#6f6f6f">The Lancet</font>

Read Full StoryMore like this
Lifetime benefits of comprehensive medical therapy in heart failure with mildly reduced or preserved ejection fraction
Naturetech

Lifetime benefits of comprehensive medical therapy in heart failure with mildly reduced or preserved ejection fraction

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5DZkxLNTI5SlF6TDBHUlBnYVVfR0g4QjdIQ1B0RkhaRHM3ajlKSjlFREh1VVU1Y3FCMFNKSms1MmVIWGJOTUYtenNudlFjcGoyRGlDaXozZVdmamplOVZN?oc=5" target="_blank">Lifetime benefits of comprehensive medical therapy in heart failure with mildly reduced or preserved ejection fraction</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
More people are living 5 years after cancer diagnosis
Northwestern Now Newsgeneral

More people are living 5 years after cancer diagnosis

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNeTUzQVYtSkdOb2x6YVZJVzRXS2YzQXAxbWpzS05fMVZRNGlHTGpDYVozYlA2aHBTUGpsb2FhWE5KZGlLR0NtQ085U3FpaEJ4bi1VamctM25MN0tWalN2V19iY2djemNtVXozYVFNY2dySmFCamhnbEpudjdIM0ZhM3cxZW9JREJIMGRSUlh6UHpyVXFnWm5HMlNiMFVYWUph?oc=5" target="_blank">More people are living 5 years after cancer diagnosis</a>  <font color="#6f6f6f">Northwestern Now News</font>

Read Full StoryMore like this
SARMAAN: How Nigeria can turn child survival gains into stronger national policy
The Sun Nigeriatech

SARMAAN: How Nigeria can turn child survival gains into stronger national policy

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxOQWppb3FaRXRqZlkxTFJLOUxnME9JU1o4NnB3WUdoRV9VQ0swbF84SUE1NFZMTDBkQ2s0MVNERkZyQ3EyYVdwMXNZUjQxYVlBc2Z5RnVQejhmNjRpWW9xVHRQeWF5M1NQUGVZSm9wNVFQdHd4MTlGdkM1Z3Q5QVdrY2NYTVRMRGYyOXA5WS01bjNFR1hVZHpTUlcxYi1DY2s?oc=5" target="_blank">SARMAAN: How Nigeria can turn child survival gains into stronger national policy</a>  <font color="#6f6f6f">The Sun Nigeria</font>

Read Full StoryMore like this
Despite gains in bone marrow transplant survival, late mortality still a concern, study finds
The University of Alabama at Birminghamtech

Despite gains in bone marrow transplant survival, late mortality still a concern, study finds

<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxQdDBpcEg2NzM2aVYwbFFnMzd5NDhzY3h0bGVVX2ZxRm9pUnB0UG9hbWFhNHhSUll5SzBVOC1LeFVDTWZQR3Y3dm9pdm4tV0ZnOGJCc2JzeGNldFd3WWdWb1Q5aDZMbEszTzBOcHg2MlJQQTJJalZZTkszTTVMWGltbHZYU0liakVDZmt3cGYxaXNQcGNRZ2RPV1VkTDRWUDJsLXNaa2JXQVJ6cjZqYzNxeHFGQUxCUUNRc1I4ZmtubnhwenFNeUcxeFJjS2g0QWllQmVJbzR6OA?oc=5" target="_blank">Despite gains in bone marrow transplant survival, late mortality still a concern, study finds</a>  <font color="#6f6f6f">The University of Alabama at Birmingham</font>

Read Full StoryMore like this
"Long-Term Survival Gains" — Live Google News Trends & Headlines